Your data on MRCVSonline
The nature of the services provided by Vision Media means that we might obtain certain information about you.
Please read our Data Protection and Privacy Policy for details.

In addition, (with your consent) some parts of our website may store a 'cookie' in your browser for the purposes of
functionality or performance monitoring.
Click here to manage your settings.
If you would like to forward this story on to a friend, simply fill in the form below and click send.

Your friend's email:
Your email:
Your name:
 
 
Send Cancel

Mixed breed dogs less disease-prone than purebreds
“There has been a long-standing perception that mixed breed dogs are less disease-prone than purebred dogs.” 
Study reveals genetic conditions dogs are most susceptible to

Genetic testing can help breeders, owners and vets identify diseases in dogs and enable preventative care, according to new research.

Writing in the journal PLOS Genetics, researchers describe how they examined more than 100,000 dogs for the presence of 152 genetic mutations. Some of the diseases tested include progressive retinal atrophy, hyperuricosuria and collie eye anomaly.

They found that testing is important to help owners know if their dog is at risk for genetic disease and to consult with their veterinary surgeon about a preventative care plan. Interestingly, the researchers also found that fewer mixed breeds were affected by the diseases tested than purebreds.

The study was conducted by Wisdom Health, a business unit of Mars Petcare, and technology company Genoscoper Laboratories.

“There has been a long-standing perception that mixed breed dogs are less disease-prone than purebred dogs,” said Cindy Cole, general manager at Wisdom Health. “This DNA-testing-based evidence shows that while mixed breed dogs are in fact less likely than purebreds to develop the recessive disorders evaluated in the study, they may still be carriers.

“Importantly it's now clear that all dogs can benefit from genetic testing. It's exciting that new diagnostic tools are now available to veterinarians, breeders and owners alike to enable them to make more informed decisions about overall care for dogs."

The study was based on a total of 152 diseases. Of these, around two out of 100 mixed breed dogs are at risk of becoming affected and 40 out of 100 are carriers for at least one of the diseases.

Approximately five out of 100 purebred dogs are at risk of becoming affected and 28 out of 100 are carriers for at least one of the diseases.      

The study also found that through healthy breeding practices, some diseases appear to have been removed from the gene pools altogether.                      

"For owners, understanding for which genetic diseases their dog is at risk can help them and their veterinarians design a personalised care and wellness program for their dog," said Jonas Donner, chief scientific officer at Genoscoper. "More broadly, for veterinarians to understand which disorders are common across the overall population is extremely valuable information for the future of proactive medical care.  

“Using genetic tools to further disease monitoring and eradication in different populations, can, over time have a positive effect on both purebred and mixed breed dogs."

Become a member or log in to add this story to your CPD history

FIVP launches CMA remedies survey

News Story 1
 FIVP has shared a survey, inviting those working in independent practice to share their views on the CMA's proposed remedies.

The Impact Assessment will help inform the group's response to the CMA, as it prepares to submit further evidence to the Inquiry Group. FIVP will also be attending a hearing in November.

Data will be anonymised and used solely for FIVP's response to the CMA. The survey will close on Friday, 31 October 2025. 

Click here for more...
News Shorts
CMA to host webinar exploring provisional decisions

The Competition and Markets Authority (CMA) is to host a webinar for veterinary professionals to explain the details of its provisional decisions, released on 15 October 2025.

The webinar will take place on Wednesday, 29 October 2025 from 1.00pm to 2.00pm.

Officials will discuss the changes which those in practice may need to make if the provisional remedies go ahead. They will also share what happens next with the investigation.

The CMA will be answering questions from the main parties of the investigation, as well as other questions submitted ahead of the webinar.

Attendees can register here before Wednesday, 29 October at 11am. Questions must be submitted before 10am on 27 October.

A recording of the webinar will be accessible after the event.